Evidence brief: Achieving greater impact from investments in medicine in Canada
| dc.contributor.author | Waddell, K | |
| dc.contributor.author | Moat, KA | |
| dc.contributor.author | Gauvin, François-Pierre | |
| dc.contributor.author | Law, M | |
| dc.contributor.author | Persaud, N | |
| dc.contributor.author | Lavis, JN | |
| dc.date.accessioned | 2024-10-21T16:09:53Z | |
| dc.date.available | 2024-10-21T16:09:53Z | |
| dc.date.issued | 2019-09 | |
| dc.description.abstract | An assessment of what is known about problems related to investments in medicine, options for addressing these problems, and key implementation considerations. The evidence brief was an input to a stakeholder dialogue on the topic of achieving greater impact from investments in medicine in Canada. | en_US |
| dc.description.sponsorship | The evidence brief and the stakeholder dialogue it was prepared to inform were funded by the Ontario SPOR SUPPORT Unit, the Canadian Institute for Health Research and the St. Michael’s Hospital Foundation. Nav Persaud, the principal investigator on these grants, also receives salary support from the Canada Research Chair program, the Department of Family and Community Medicine of St Michael’s Hospital, and the University of Toronto Department of Family and Community Medicine. | en_US |
| dc.identifier.citation | Waddell K, Moat KA, Gauvin FP, Law M, Persaud N, Lavis, JN. Evidence brief: Achieving greater impact from investments in medicine in Canada. Hamilton, Canada: McMaster Health Forum, 17 September 2019. | en_US |
| dc.identifier.issn | 1925-2250 | |
| dc.identifier.uri | http://hdl.handle.net/11375/30447 | |
| dc.language.iso | en | en_US |
| dc.subject | achieve | en_US |
| dc.subject | impact | en_US |
| dc.subject | investments | en_US |
| dc.subject | medicine | en_US |
| dc.subject | Canada | en_US |
| dc.title | Evidence brief: Achieving greater impact from investments in medicine in Canada | en_US |